News Microbix Biosystems Inc.

Equities

Market Closed - Toronto S.E. Other stock markets 03:58:33 2024-04-24 pm EDT			5-day change	1st Jan Change
0.335 ^CAD	0.00%		-4.29%	-14.10%

Mar. 27	Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call
Mar. 14	Microbix Says Clot-Buster Drug Project Advancing	MT

Microbix Presenting at the 2024 Bloom Burton Conference	Apr. 11	GL
Microbix Announces Annual and Special Meeting Voting Results	Apr. 01	GL
Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call	Mar. 27
Microbix Says Clot-Buster Drug Project Advancing	Mar. 14	MT
Microbix Brief: Says Clot-Buster Drug Project Advancing	Mar. 14	MT
Microbix’s Clot-Buster Drug Project Advances	Mar. 14	GL
Microbix?S Clot-Buster Drug Project Advances	Mar. 14	CI
Microbix Unveiling Test Controls for Head and Neck Cancer	Mar. 11	MT
Microbix Brief: Unveiling Test Controls for Head and Neck Cancer	Mar. 11	MT
Microbix Unveils Test Controls for Head and Neck Cancer	Mar. 11	GL
Microbix Unveils Test Controls for Head and Neck Cancer	Mar. 11	AQ
Microbix Biosystems Inc. Unveils Test Controls for Head and Neck Cancer	Mar. 11	CI
Microbix Announces Issuance of Stock Options	Feb. 26	GL
Microbix Higher After Reporting Record Results for Q1 Fiscal 2024	Feb. 14	MT
Transcript : Microbix Biosystems Inc., Q1 2024 Earnings Call, Feb 14, 2024	Feb. 14
Earnings Flash (MBX) MICROBIX BIOSYSTEMS Posts Q1 Revenue $8.4M	Feb. 14	MT
Microbix Reports Record Results for Q1 Fiscal 2024	Feb. 14	GL
Tranche Update on Microbix Biosystems Inc.'s Equity Buyback Plan announced on December 6, 2023.	Feb. 14	CI
Microbix Biosystems Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 14	CI
North American Morning Briefing :Stock Futures -2-	Feb. 14	DJ

No results for this search